Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ventyx Biosciences, Inc. | Chief Medical Officer | Stock Option (right to buy) | 145K | Feb 4, 2022 | Direct | ||
ALUMIS INC. | Chief Medical Officer | Common Stock (Right to Buy) | 70.8K | Jul 1, 2024 | Direct | ||
ALUMIS INC. | Chief Medical Officer | Stock Option (Right to Buy) | 64.2K | Jul 1, 2024 | Direct | ||
ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | May 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALMS | ALUMIS INC. | Jun 27, 2024 | 17 | $0 | 4 | Jul 1, 2024 | Chief Medical Officer |
ALMS | ALUMIS INC. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | Chief Medical Officer |
ALPN | ALPINE IMMUNE SCIENCES, INC. | May 20, 2024 | 3 | $0 | 4 | May 20, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jul 18, 2022 | 1 | $0 | 4 | Jul 19, 2022 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jul 18, 2022 | 0 | $0 | 3 | Jul 19, 2022 | Director |
VTYX | Ventyx Biosciences, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 4, 2022 | Chief Medical Officer |
VTYX | Ventyx Biosciences, Inc. | Oct 20, 2021 | 0 | $0 | 3 | Oct 20, 2021 | Chief Medical Officer |